Obesity

Biotech firm says much of the world will be on obesity drugs in 50 years

OBESITY drugs will become so ubiquitous in the next 50 years that much of the world will be taking them, an industry executive has said. 

Ozempic and Wegovy are just the beginning. The weight-loss drug sector is set to get more crowded and sophisticated.
EDITORIAL

Ozempic’s contradictory math has a simple answer

OZEMPIC and Wegovy have been shrinking people’s bottoms, and now they might also be shrinking corporations’ bottom lines. What happens when people eat less, drink less, and eventually weigh less? The ...